These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32684992)

  • 1. Nebuliser hygiene in cystic fibrosis: evidence-based recommendations.
    Bell J; Alexander L; Carson J; Crossan A; McCaughan J; Mills H; O'Neill D; Moore JE; Millar BC
    Breathe (Sheff); 2020 Jun; 16(2):190328. PubMed ID: 32684992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebuliser cleaning and disinfection practice in the home among patients with cystic fibrosis.
    MacFarlane M; Carson L; Crossan A; Bell J; Moore JE; Millar BC
    J Infect Prev; 2020 Jan; 21(1):14-22. PubMed ID: 32030099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebuliser systems for drug delivery in cystic fibrosis.
    Daniels T; Mills N; Whitaker P
    Cochrane Database Syst Rev; 2013 Apr; (4):CD007639. PubMed ID: 23633344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes to cross infection, nebuliser hygiene and antimicrobial resistance in people with cystic fibrosis: Results of an international survey.
    Millar BC; Rendall JC; Moore JE
    Infect Dis Health; 2024 Nov; 29(4):185-195. PubMed ID: 38644104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of nebulised antibiotic delivery in cystic fibrosis.
    Wilson D; Burniston M; Moya E; Parkin A; Smye S; Robinson P; Littlewood J
    Arch Dis Child; 1999 Apr; 80(4):348-52. PubMed ID: 10086942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary deposition of nebulised amiloride in cystic fibrosis: comparison of two nebulisers.
    Thomas SH; O'Doherty MJ; Graham A; Page CJ; Blower P; Geddes DM; Nunan TO
    Thorax; 1991 Oct; 46(10):717-21. PubMed ID: 1750018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost effectiveness of dry powder antibiotics for the treatment of Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tappenden P; Harnan S; Uttley L; Mildred M; Walshaw M; Taylor C; Brownlee K
    Pharmacoeconomics; 2014 Feb; 32(2):159-72. PubMed ID: 24338264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungal contamination of nebuliser devices used by people with cystic fibrosis.
    Peckham D; Williams K; Wynne S; Denton M; Pollard K; Barton R
    J Cyst Fibros; 2016 Jan; 15(1):74-7. PubMed ID: 26104996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008649. PubMed ID: 29424930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2020 May; 5(5):CD008649. PubMed ID: 32358807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily Observations of Nebuliser Use and Technique (DONUT) in children with cystic fibrosis.
    Bos AC; Tiddens HA; Tong Minh K; Heeres I; Overweel-Uijterlinde JL; Kok AE; Andrinopoulou ER; Janssens HM
    J Cyst Fibros; 2016 Sep; 15(5):645-51. PubMed ID: 27052127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for improving adherence to airway clearance treatment and exercise in people with cystic fibrosis.
    Jones M; Moffatt F; Harvey A; Ryan JM
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD013610. PubMed ID: 37462324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannitol delivery by vibrating mesh nebulisation for enhancing mucociliary clearance.
    Chan JG; Kwok PC; Young PM; Chan HK; Traini D
    J Pharm Sci; 2011 Jul; 100(7):2693-702. PubMed ID: 21283985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study.
    Hogan A; Bonney MA; Brien JA; Karamy R; Aslani P
    Int J Clin Pharm; 2015 Feb; 37(1):86-93. PubMed ID: 25432693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern.
    Newman SP; Woodman G; Clarke SW
    Thorax; 1988 Apr; 43(4):318-22. PubMed ID: 3406919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Survey of Cystic Fibrosis Center Recommendations for Nebulizer Cleaning and Disinfection.
    Kenkare ZJ; Rearick J; Schramm CM; Murray TS; Collins MS
    Respir Care; 2024 Jul; ():. PubMed ID: 39013569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary deposition of colistin aerosols in cystic fibrosis. Comparison of an ultrasonic nebulizer and a pneumatic nebulizer].
    Gagnadoux F; Diot P; Marchand S; Thompson R; Dieckman K; Lemarié E; Varaigne F; Maurage C; Baulieu JL; Rolland JC
    Rev Mal Respir; 1996; 13(1):55-60. PubMed ID: 8650418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.